We’re looking for women ages 18-42 to participate in The GRACE Study.
Interested in IVF treatment?
If you are a woman between the ages of 18 and 42 who has been diagnosed with infertility (difficulty becoming pregnant), with regular menstrual cycles (every 21-35 days), you may be eligible for participation in this study.
Compensation
If eligible, you will receive your study-related treatment at no cost, including up to two COS cycles, PGT-A, and up to three FET cycles. All study-related medication will be provided at no cost.
About the Sponsor
Granata Bio is a biopharma company exclusively focused on identifying and developing innovative therapies that expand access and improve outcomes in reproductive health.
About the Study
The GRACE investigational study is a multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an assisted reproductive technology (ART) cycle in women.
The investigational study includes up to two controlled ovarian stimulation (COS) cycles with PGT-A (chromosome screening of embryos) and, if you are eligible, up to three frozen embryo transfer (FET) cycles.
Find a participating IVF clinic near you to enroll
-
HRC Fertility | Encino, CA | Contact
-
Illume Fertility | Norwalk, CT | Contact
-
Reproductive Associates of Delaware CCRM | Newark, DE | Contact
-
-
RBA | Atlanta, GA | Contact
-
Fertility Institute of Hawaii | Honolulu, HI | Contact
-
Fertility Centers of Illinois | Chicago, IL | Contact
-
Boston IVF | Waltham, MA | Contact
-
Shady Grove Fertility - Rockville | Rockville, MD | Contact
-
-
Pinnacle Fertility Oregon | Portland, OR | Contact
-
Main Line Fertility | Bryn Mawr, PA
-